Five biomarkers including PTPN1, COPZ1, FAXDC2, SLC14A1s and NAMPT distinguished PSP from HC with a 69% diagnostic accuracy. The gene discussed is FAXDC2; the disease is supranuclear palsy, progressive, 1.